1. Sudden death in mild hypertrophic cardiomyopathy with compound DSG2/DSC2/MYH6 mutations: Revisiting phenotype after genetic assessment in a master runner athlete.
- Author
-
Castellana S, Mastroianno S, Palumbo P, Palumbo O, Biagini T, Leone MP, De Luca G, Potenza DR, Amico CM, Mazza T, Russo A, Di Stolfo G, and Carella M
- Subjects
- Atrioventricular Block complications, Atrioventricular Block genetics, Cardiac Myosins genetics, Cardiomyopathy, Hypertrophic complications, Desmocollins genetics, Desmoglein 2 genetics, Diagnosis, Differential, Electrocardiography, Humans, Middle Aged, Mutation, Myosin Heavy Chains genetics, Pacemaker, Artificial, Phenotype, Prognosis, Tachycardia, Ventricular complications, Tachycardia, Ventricular genetics, Athletes, Cardiomyopathy, Hypertrophic genetics, Death, Sudden, Cardiac etiology
- Abstract
Cardiomyopathies represent a well-known cause of heart failure and sudden death. Although cardiomyopathies are generally categorized in distinct nosographic entities, characterized by single gene-to-disease causal relationships, recently, oligogenic mutations have also been associated to relevant cardiac clinical features. We report the case of a master athlete carrying trigenic mutations in desmoglein-2 (DSG2), desmocollin-2 (DSC2) and heavy chain myosin 6 (MYH6), which determine a mild hypertrophic phenotype associated both to ventricular tachyarrhythmias and atrio-ventricular block. We discuss the differential diagnosis and prognostic approach in patient affected by complex cardiomyopathy phenotype, along with the importance of sport restriction and sudden death prevention., (Copyright © 2019 Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF